# Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia

> **NCT06176456** · NA · UNKNOWN · sponsor: **Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev** · enrollment: 60 (estimated)

## Conditions studied

- Catatonia
- Schizophrenia
- Schizo Affective Disorder
- Bipolar Affective Disorder

## Interventions

- **DIAGNOSTIC_TEST:** rTMS
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06176456
- **Lead sponsor:** Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06176456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06176456, "Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06176456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*